Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases

CNS Oncol. 2014 Jul;3(4):275-85. doi: 10.2217/cns.14.28.

Abstract

Objective: To validate the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 for brain metastases.

Methods: Patients with brain metastases and their healthcare professionals (HCPs) assessed the relevance of the BASIQ on a 0-10 scale with 10 as extremely relevant.

Results: A total of 52 patients and 20 HCPs participated in this study. In total, 95% of HCPs and 85% of patients found all items relevant. Balance and walking ability were rated relevant by 100% of patients and HCPs. Headache, nausea, energy, memory and ability to do housework were also rated relevant by 100% of HCPs. Over 95% of patients determined the items of ability to do housework, tiredness, energy, vision, memory and putting ideas into words as relevant. There were no items rated below 7 by patients or below 5 by HCPs.

Conclusion: This study indicates that BASIQ version 1.0 has valid content items encompassing disease-related symptom and impact on daily living.

Keywords: BASIQ; brain metastases; content validation; quality of life; questionnaire.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms / psychology*
  • Brain Neoplasms / secondary*
  • Female
  • Health Personnel / psychology
  • Humans
  • Male
  • Middle Aged
  • Quality of Life*
  • Reproducibility of Results
  • Surveys and Questionnaires
  • Young Adult